The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells

Transplantation

Volumn 81, Issue 5, 2006, Pages 726-735

  Kapessidou, Yota ^a   Habran, Claude ^a   Buonocore, Sofia ^a   Flamand, Véronique ^a   Barvais, Luc ^a   Goldman, Michel ^a   Braun, Michel Y ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Institute for Medical Immunology   (Belgium)

Author keywords

Cardiac vasculopathy; Endothelium; Inflammation; Rejection; Vasculogenesis

Indexed keywords

HY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; HLA ANTIGEN CLASS 2; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; BONE MARROW; CARDIOVASCULAR DISEASE; CD4+ T LYMPHOCYTE; CORRELATION ANALYSIS; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IRRADIATION; MALE; MOUSE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; ALLOTRANSPLANTATION; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; CBA MOUSE; IMMUNOLOGY; MOLECULAR GENETICS; PHYSIOLOGY;

ANIMALS; ANTIGEN-PRESENTING CELLS; BLOOD VESSELS; CD4-POSITIVE T-LYMPHOCYTES; DNA-BINDING PROTEINS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; GRAFT REJECTION; H-2 ANTIGENS; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; MALE; MICE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN; TRANSPLANTS; AMINO ACID SEQUENCE; MICE, INBRED C57BL; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL; TRANSPLANTATION, HOMOLOGOUS;

EID: 33645056960     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000184444.93108.d1     Document Type: Article

References (61)

1. Orbaek Andersen H. Heart allograft vascular disease: an obliterative vascular disease in transplanted hearts. Atherosclerosis 1999; 142: 243.
2. Day JD, Rayburn BK, Gaudin PB, et al. Cardiac allograft vasculopathy: the central pathogenetic role of ischemia-induced endothelial cell injury. J Heart Lung Transplant 1995; 14: S142.
3. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313.
4. Lee RS, Yamada K, Houser SL, et al. Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. Proc Natl Acad Sci USA 2001; 98: 3276.
5. Pietra BA, Wiseman A, Bolwerk A, et al. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J Clin Invest 2000; 106: 1003.
6. Vella JP, Vos L, Carpenter CB, Sayeg MH. Role of indirect allorecognition in experimental late acute rejection. Transplantation 1997; 64: 1823.
7. Honjo K, Xu XY, Bucy RP. Heterogeneity of T cell clones specific for a single indirect alloantigenic epitope (I-Ab/H-2Kd54-68) that mediate transplant rejection. Transplantation 2000; 70: 1516.
8. Talmage DW, Dart G, Radovich J, Lafferty KJ. Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection. Science 1976; 191: 385.
9. Lechler RI, Batchelor JR. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982; 155: 31.
10. Lakkis FG, Arakelov A, Konieczny BT, Inoue Y. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000; 6: 686.
11. Braun MY, McCormack A, Webb G, Batchelor JR. Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitization. Transplantation 1993; 55: 177.
12. Benichou G, Valujskikh A, Heeger PS. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 1999; 162: 352.
13. Vella JP, Spadafora-Ferreira M, Murphy B, et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997; 64: 795.
14. Valujskikh AD, Matesic A, Gilliam D, et al. cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice. J Clin Invest 1998; 101: 1398.
15. Steeber DA, Tedder TF. Adhesion molecule cascades direct lymphocytes recirculation and leukocyte migration during inflammation. Imunol Res 2000; 22: 299.
16. Kreisel D, Krupnick AS, Szeto WS, et al. A simple -method for culturing mouse vascular endothelium. J Immunol Methods 2001; 254: 31.
17. Marelli-Berg FM, Hargreaves RE, Carmichael P, et al. Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells. J Exp Med 1996; 183: 1603.
18. Pober JS, Collins T, Gimbrone MA Jr., et al. Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation 1986; 41: 141.
19. Karin N, Szafer F, Mitchell D, et al. Selective and nonselective stages in homing of T lymphocytes to the central nervous system during experimental allergic encephalomyelitis. J Immunol 1993; 150: 4116.
20. Kawai T, Shimauchi H, Eastcott JW, et al. Antigen direction of specific T-cell clones into gingival tissues. Immunology 1993; 93: 11.
21. Weis M, von Scheidt, W. Cardiac allograft vasculopathy: a review. Circulation 1997; 96: 2069.
22. Briscoe DM, Alexander SI, Lichtman AH. Interactions between T lymphocytes and endothelial cells in allograft rejection. Curr Opin Immunol 1998; 10: 525.
23. Shi Q, Rafii S, Wu MH, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362.
24. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434.
25. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221.
26. Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002; 105: 3017.
27. Rafii S. Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest 2000; 105: 17.
28. Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, et al. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 2001; 357: 33.
29. Sinclair RA. Origin of endothelium in human renal allografts. BMJ 1972; 4: 15.
30. Williams GM, ter Haar A, Parks LC, Krajewski CA. Endothelial changes associated with hyperacute, acute, and chronic renal allograft rejection in man. Transpl Proc 1973; 5: 819.
31. Valujskikh A, Lantz O, Celli S, et al. Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway. Nat Immunol 2002; 3: 844.
32. Lantz O, Grandjean I, Matzinger P, Di Santo JP. Gamma chain required tor naive CD4+ T cell survival but not for antigen proliferation. Nat Immunol 2000; 1: 54.
33. Braun MY, Grandjean I, Feunou P, et al. Acute rejection in the absence of cognate recognition of allograft by T cells. J Immunol 2001; 166: 4879.
34. Buonocore S, Flamand V, Goldman M, Braun MY. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft. Transplantation 2003; 75: 407.
35. Eiref SD, Zhang W, Popma SH, et al. Creation of chimeric hearts via bone marrow transplantation: a new tool for testing the "passenger leukocyte" hypothesis. Ann Thorac Surg 1997; 64: 628.
36. Scott D, Addey C, Ellis P, et al. Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens. Immunity 2000; 12: 711.
37. Vella JP, Magee C, Vos L, et al. Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides. Transplantation 1999; 67: 1523.
38. Valujskikh A, Matesic D, Gilliam A, et al. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice. J Clin Invest 1998; 101: 1398.
39. de Waal RM, Bogman MJ, Cornelissen IM, et al. Expression of donor class I major histocompatibility antigens on the vascular endothelium of mouse skin allografts. Transplantation 1986; 42: 178.
40. de Waal RM, Bogman MJ, Maass CN, et al. Variable expression of Ia antigens on the vascular endothelium of mouse skin allografts. Nature 1983; 303: 426.
41. Offner H, Buenafe AC, Vainiene M, et al. Where, when, and how to detect biased expression of disease-relevant V beta genes in rats with experimental autoimmune encephalomyelitis. J Immunol 1993; 151: 506.
42. Karin N, Szafer F, Mitchell D, et al. Selective and nonselective stages in homing of T lymphocytes to the central nervous system during experimental allergic encephalomyelitis. J Immunol 1993; 150: 4116.
43. Kawai T, Shimauchi H, Eastcott JW, et al. Antigen direction of specific T-cell clones into gingival tissues. Immunology 1998; 93: 11.
44. Marelli-Berg FM, Frasca L, Weng L, et al. Antigen recognition influences transendothelial migration of CD4+ T cells. J Immunol 1999; 162: 696.
45. Marelli-Berg FM, Jarmin SJ. Antigen presentation by the endothelium: a green light for antigen-specific T cell trafficking? Immunol Lett 2004; 93: 109.
46. Kreisel D, Krasinskas AM, Krupnick AS, et al. Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection. J Immunol 2004; 173: 3027.
47. Miller DW, Graulich W, Karges B, et al. Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells. Int J Cancer 1999; 81: 568.
48. Duff SE, Li C, Garland JM, Kumar S. CD105 is important for angiogenesis: evidence and potential applications. FASEB J 2003; 17: 984.
49. Hayry P, Isoniemi H, Yilmaz S, et al. Chronic allograft rejection. Immunol Rev 1993; 134: 33.
50. Hruban RH, Beschorner WE, Baumgartner WA, et al. Accelerated arteriosclerosis in heart transplant recipients is associated with a T lymphocyte-mediated endothelialitis. Am J Pathol 1990; 137: 871.
51. Gao EK, Kosaka H, Surh CD, Sprent J. T cell contact with Ia antigens on nonhemopoietic cells in vivo can lead to immunity rather than tolerance. J Exp Med 1991; 174: 435.
52. Rose ML, Coles MI, Griffin RJ, et al. Expression of class I and class II major histocompatibility antigens in normal and transplanted human heart. Transplantation 1986; 41: 776.
53. Hasegawa S, Becker G, Nagano H, et al. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells. Am J Pathol 1998; 153: 69.
54. Van der Meeren A, Vandamme M, Squiban C, et al. Inflammatory reaction and changes in expression of coagulation proteins on lung endothelial cells after total-body irradiation in mice. Radiat Res 2003; 160: 637.
55. Boerma M, Kruse JJ, van Loenen M, et al. Increased deposition of von Willebrand factor in the rat heart after local ionizing irradiation. Strahlenther Onkol 2004; 180.
56. Mouthon MA, Vereycken-Holler V, Van der Meeren A, Gaugler MH. Irradiation increases the interactions of platelets with the endothelium in vivo: analysis by intravital microscopy. Radiat Res 2003; 160: 593.
57. Krasinskas AM, Eiref SD, McLean AD, et al. Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection. Transplantation 2000; 70: 514.
58. + TCR transgenic mouse. Am J Transplant 2003; 3: 381.
59. Wang Z, Castellaneta A, De Creus A, et al. Heart, but not skin, allografts from donors lacking Flt3 ligand exhibit markedly prolonged survival time. J Immunol 2004; 172: 5924.
60. McDouall RM, Batten P, McCormack A, et al. MHC class II expression on human heart microvascular endothelial cells: exquisite sensitivity to interteron-gamma and natural killer cells. Transplantation 1997; 64: 1175.
61. Chen Y, Demir Y, Valujskikh A, Heeger PS. Antigen location contributes to the pathological features of a transplanted heart graft. Am J Pathol 2004; 164: 1407.